Reasonable people may disagree re the efficacy and possible ST and LT effects of these vaccines (or gene therapies, which are a better way to describe the Pfizer and Moderna mRNA injections), since they are on EUA.
The compensation levels behind these numbers are interesting. Remember that total comp is salary, options, stock awards, bonuses, and non-equity compensation (e.g. a cash bonus)--not just salary and bonus.
Salary.com did an analysis on MFN's comp. This is 2019 where his comp was $26 million: https://www1.salary.com/Michael-F-Neidorff-Salary-Bonus-Stock-Options-for-CENTENE-CORP.html
His salary is actually fairly reasonable among this CEO group--I'm sure for tax reasons--but at the end of the day, he and his family will be among the largest shareholders of Centene in the future, as this is not the only year he's received stock awards and options. Notice the options (options are money in to the company when exercised) are relatively small. The stock awards, which are free and clear, apparently are vested, are extremely high.
He, and his family / family trust, by the sheer amount of stock, will retain a great deal of control over the company even if he retires, which, for a company receiving a huge amount of public taxpayer money, is dodgy at best:
$1,500,000 Base Pay
$7,065,000 Bonus + Non-Equity Incentive Comp
$8,565,000 Total Cash Comp
$16,999,987 Stock Award Value
$380,360 Option Award Value
$17,380,347 Total Equity
$493,078 Total Other
$26,438,425 Total Compensation
The right thing to do this year would have been to turn back his bonus 100% and also to tail off on the stock awards. This is supposedly a public company. At his age MFN has plenty in the bank over 25 years of CEO-dom. Frankly, this is not his company. But he sure acts like it.